Neurana Pharmaceuticals
Dr. Brisson joined Neurana Pharmaceuticals in 2018 and is currently Vice President of Regulatory Affairs and Quality. Dr. Brisson has more than 20 years of experience in the biotechnology, pharmaceutical, and medical device industries with strong expertise and broad scientific and operational understanding in regulatory strategy, quality, manufacturing operations, and product/process development areas. Prior to Neurana, Dr. Brisson held positions in both startups and established companies, most recently as Chief Operating Officer at Stellar Biotechnologies. Earlier roles were focused on quality and regulatory operations at MacuSight and Teva Parenteral Products.
Dr. Brisson holds a Ph.D. in Chemistry from the University of North Carolina.
This person is not in any offices
Neurana Pharmaceuticals
Neurana Pharmaceuticals is a privately-held clinical-stage San Diego-based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders.